期刊
CRYSTAL GROWTH & DESIGN
卷 10, 期 8, 页码 3585-3595出版社
AMER CHEMICAL SOC
DOI: 10.1021/cg1004853
关键词
-
资金
- AstraZeneca
- National Science Foundation Engineering Research Center for Structured Organic Particulate Systems (NSF ERC-SOPS) [EEC-0540855]
- School of Pharmacy, Purdue University
The purpose of the present study was to investigate the effect of molecular weight (MW) and concentration of a polymeric additive, poly(vinyl pyrrolidone) (PVP), on the crystal growth rate of a small molecule drug, felodipine. PVP samples with three different molecular weights (2-3 x 10(3) g/mol for PVP K-12, 4-5 x 10(4) g/mol for PVP K-29/32, and 1-1.5 x 10(6) g/mol for PVP K-90) were used to study the effect of molecular weight. Optical microscopy was used to measure the growth rates at various temperatures in the range of 70-110 degrees C. While PVP was found to reduce the crystal growth rate at all temperatures, the inhibitory effect was much greater at lower temperatures. The inhibiting effect of PVP on the crystal growth rate of felodipine increased as a function of polymer molecular weight. The effect of polymer concentration on the crystal growth rate was investigated with varying concentrations of PVP K-29/32 (0.5-4.5 wt %), and a log linear relationship between crystal growth rate and concentration was observed. The calorimetric glass transition temperatures (T-g) of the solid dispersions were not significantly different from the T-g of pure felodipine. IR spectroscopy results indicate that among the PVP polymers of three different MWs, there is no difference in their hydrogen-bonding interactions with felodipine molecules. We present discussions of these experimental results with reference to established thermodynamic theories of crystallization kinetics and mass transfer models.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据